Tools

LEADER 02019cam a2200457 i 4500

001 ocn951671365;

003 OCoLC;

005 20160614081836.0;

006 m o d f ;

007 cr m||||||||||;

008 160614s2013 dcua ob f000 0 eng c;

040 a| GPOb| enge| rdae| pnc| GPOd| MvI;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0445-B-07 (online);

086 0 a| HE 1.75:OEI-04-11-00510;

088 a| OEI-04-11-00510;

245 10 a| FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety.;

246 3 a| Food and Drug Administration lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety;

246 1 i| Running title:a| FDA lacks comprehensive data to determine whether REMS improve drug safety;

264 1 a| [Washington, D.C.] :b| Department of Health and Human Services, Office of Inspector General,c| 2013.;

300 a| 1 online resource (34 pages) :b| illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Title from title screen (viewed June 13, 2016).;

500 a| "February 2013.";

500 a| "OEI-04-11-00510.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

650 0 a| Medicare.=| ^A6515;

610 10 a| United States.b| Food and Drug Administrationx| Auditing.=| ^A1253;

856 40 u| https://purl.fdlp.gov/GPO/gpo68938;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 4459078;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4459078-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 7/11/2016x| EDOCUMENTz| JERESOURCE;

FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety.

Author/creator	United States
Format	Electronic
Publication	[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2013.
Description	1 online resource (34 pages) : illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo68938
Subjects	United States. Food and Drug Administration--Auditing. Medicare. Drugs--Risk assessment. --United States. --Evaluation. Drugs--United States. --Safety measures. --Evaluation.

Variant title	Food and Drug Administration lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety
Variant title	Running title: FDA lacks comprehensive data to determine whether REMS improve drug safety
General note	Title from title screen (viewed June 13, 2016).
General note	"February 2013."
General note	"OEI-04-11-00510."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Technical rpt number	OEI-04-11-00510
GPO item number	0445-B-07 (online)
Govt. docs number	HE 1.75:OEI-04-11-00510

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title